Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
RegistrantFRESENIUS KABI (SINGAPORE) PTE LTD
Product Classification
D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification
Formulation Information
INJECTION, SOLUTION
INTRAVENOUS
Medical Information
V03AB35
sugammadex
Manufacturer Information
FRESENIUS KABI (SINGAPORE) PTE LTD
Labesfal - Laboratórios Almiro, S.A.
Active Ingredients
Documents
Package Inserts
Sugammadex Kabi Solution for Injection PI.pdf
Approved: April 19, 2024